首页> 外文期刊>Biomacromolecules >Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
【24h】

Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications

机译:用于生物医学应用纤维素纳米晶体体内评价的放射性标记分子成像探针

获取原文
获取原文并翻译 | 示例
           

摘要

Cellulose nanocrystals (CNCs) have remarkable potential to improve the delivery of diagnostic and therapeutic agents to tumors; however, the in vivo studies on CNC biodistribution are still limited. We developed CNC-based imaging probes for the in vitro and in vivo evaluation using two labeling strategies: site -specific hydrazone linkage to the terminal aldehyde of the CNC and nonsite-specific activation using 1,1'-carbonyldiimidazole (CDI). The in vivo behavior of unmodified CNC, DOTA-CNC (ald.), and DOTA-CNC (OH) was investigated in healthy and 4T1 breast cancer mouse models. They displayed good bio-compatibility in cell models. Moreover, the biodistribution profile and SPECT/CT imaging confirmed that the accumulation of In-111 -labeled DOTA-CNC (and.) and In-111-DOTA-CNC (OH) was primarily in hepatic, splenic, and pulmonary ducts in accordance with the clearance of nontargeted nanoparticles. The developed CNC imaging probes can be used to obtain information with noninvasive imaging on the behavior in vivo to guide structural optimization for targeted delivery.
机译:纤维素纳米晶(CNC)具有显着的潜力,可改善诊断和治疗剂对肿瘤的递送;然而,关于数控生物分布的体内研究仍然有限。我们使用两种标记策略开发了基于CNC的成像探针和体内评价:使用1,1'-碳二咪唑(CDI)对CNC的末端醛和无烟灰激活的含量分析的腙键合。在健康和4T1乳腺癌小鼠模型中研究了未修饰的CNC,DOTA-CNC(ALD。)和DOTA-CNC(OH)的体内行为。它们在单元格模型中显示出良好的生物兼容性。此外,生物分布曲线和SPECT / CT成像证实,111中标记的DOTA-CNC(和。)和111-型-CNC(OH)的积累主要是肝,脾和肺管道随着非靶向纳米颗粒的间隙。开发的CNC成像探针可用于获得具有非侵入性成像的信息,以指导针对目标递送的结构优化的行为。

著录项

  • 来源
    《Biomacromolecules》 |2019年第2期|共10页
  • 作者单位

    Univ Helsinki Dept Chem Radiochem FI-00014 Helsinki Finland;

    Univ Helsinki Dept Chem Radiochem FI-00014 Helsinki Finland;

    Univ Helsinki Dept Chem Radiochem FI-00014 Helsinki Finland;

    Univ Helsinki Fac Pharm Div Pharmaceut Chem &

    Technol Drug Res Program FI-00014 Helsinki Finland;

    Aalto Univ Dept Bioprod &

    Biosyst Biohybrid Mat FI-00076 Espoo Finland;

    Univ Helsinki Fac Pharm Div Pharmaceut Chem &

    Technol Drug Res Program FI-00014 Helsinki Finland;

    Univ Helsinki Dept Chem Radiochem FI-00014 Helsinki Finland;

    Aalto Univ Dept Bioprod &

    Biosyst Biohybrid Mat FI-00076 Espoo Finland;

    Univ Helsinki Dept Chem Radiochem FI-00014 Helsinki Finland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号